Zepp Health (ZEPP) Stock Price, News & Analysis

Company Overview

Zepp Health Corporation is a wearable technology company that develops smart health and fitness products, software, and related services. Its portfolio includes smartwatches, fitness trackers, smart scales, and other connected devices designed to help users monitor activity, sleep, heart health, and other wellness data.

The company markets products primarily under the Amazfit and Zepp brands. Its offerings combine wearable hardware with mobile applications and cloud-based services that provide health insights, workout tracking, sleep analysis, sports guidance, and device management. Zepp Health has also expanded into hearing-related technology through its Zepp Clarity brand.

Founded in 2013 as Huami Corporation, the company changed its name to Zepp Health Corporation in 2021 to reflect its broader focus on digital health and wellness. It serves customers in international markets through online and retail channels, with products available across North America, Europe, Asia, and other regions. Wang Huang is the company's founder, chairman, and chief executive officer.

Key Stats

• Today's Range: $3.63 to $3.93
• 50-Day Range: $3.85 to $5.76
• 52-Week Range: $3.63 to $61.85
• Volume: 25,934 shs
• Average Volume: 38,948 shs
• Market Capitalization: $56.52 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $53.01
• Consensus Rating: Hold

Zepp Health Stock Analysis - MarketRank™

Zepp Health scored higher than 53% of companies evaluated by MarketBeat, and ranked 297th out of 479 stocks in the consumer discretionary sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Hold

Consensus Rating

Zepp Health has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, 1 buy rating, no hold ratings, and 1 sell rating.

Upside Potential

Zepp Health has a consensus price target of $53.01, representing about 1,276.9% upside from its current price of $3.85.

Amount of Analyst Coverage

Zepp Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Zepp Health is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Zepp Health is -1.40, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Zepp Health has a P/B Ratio of 0.26. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

3.42% of the float of Zepp Health has been sold short.

Short Interest Ratio / Days to Cover

Zepp Health has a short interest ratio ("days to cover") of 4.55.

Change versus previous month

Short interest in Zepp Health has recently decreased by 6.93%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Zepp Health does not currently pay a dividend.

Dividend Growth

Zepp Health does not have a long track record of dividend growth.

News and Social Media

• Score: 0.6 / 5
• News Sentiment: N/A

Search Interest

Only 1 people have searched for ZEPP on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.

MarketBeat Follows

1 people have added Zepp Health to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 2.1 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Zepp Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $42,107.00 in company stock.

Percentage Held by Insiders

36.00% of the stock of Zepp Health is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

52.61% of the stock of Zepp Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 5/19/2025
• Today: 10/06/2026
• Next Earnings (Estimated): 11/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Consumer Discretionary
• Industry: Household Durables
• Sub-Industry: Consumer Electronics
• Current Symbol: NYSE:ZEPP
• CIK: 1720446
• Web: www.zepp.com
• Phone: 861059403268
• Fax: N/A
• Employees: 763
• Year Founded: 2012

Price Target and Rating

• Average Price Target for Zepp Health: $53.01
• High Price Target: $53.01
• Low Price Target: $53.01
• Potential Upside/Downside: +1,276.9%
• Consensus Rating: Hold
• Rating Score (0-4): 2.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($2.75)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$40.07 million
• Net Margins: -15.78%
• Pretax Margin: -14.01%
• Return on Equity: -19.64%
• Return on Assets: -7.18%

Debt

• Debt-to-Equity Ratio: 0.30
• Current Ratio: 0.90
• Quick Ratio: 0.70

Sales & Book Value

• Annual Sales: $258.90 million
• Price / Sales: 0.22
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $14.61 per share
• Price / Book: 0.26

Miscellaneous

• Outstanding Shares: 14,680,000
• Free Float: 9,395,000
• Market Cap: $56.52 million
• Optionable: Optionable
• Beta: 1.80